In Victoria, British Columbia,
Michael Ball is the relatively new (September 2004) CEO of Genologics. The company is a scientific/medical laboratory information management system vendor, which specializes in
proteomics. The company partners with IBM and
the Genome British Columbia Proteomics Centre, which is 20 years old. Privately held Genologics' main product is ProteusLIMS, which aims to streamline drug development and marketing.
No comments:
Post a Comment